Get started
Author

Alexandre A. Tavartkiladze

Observed names: A Tavartkiladze, A. Tavartkiladze, A.A. Tavartkiladze, ALEXANDRE TAVARTKILADZE, Alexandre Tavartkiladze, Tavartkiladze A, Tavartkiladze A.
Observed institutions: Délégation Paris 5, Université Paris Cité, Foxconn (China), David Tvildiani Medical University, National Cancer Center of Georgia, Precision Research (United States), Tbilisi State Medical University
ORCID: 0000-0002-9589-7417
Observed ORCID: 0000-0002-9589-7417
OpenAlex ID: A5011436749
Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer
2022 · Ying Cheng, Liang Han, et al. · JAMA · 487
First-Line Serplulimab in Extensive-Stage Small Cell Lung Cancer
2026 · Jingjing Liu, Liang Han, et al. · JAMA Oncology · 3
[Expression of epidermal growth factor receptor and concentrations of epidermal growth factor and melatonin in endometrial carcinoma].
2014 · N Dznelashvili, D Kasradze, et al. · PubMed · 3
The study of melatonin protective activity on pancreatic β-cells under the condition of alloxan-induced diabetes during aging.
2010 · D Kasradze, A Tavartkiladze, et al. · PubMed · 3
Melatonin Biosynthesis, Receptors, and the Microbiota–Tryptophan–Melatonin Axis: A Shared Dysbiosis Signature Across Cardiac Arrhythmias, Epilepsy, Malignant Proliferation, and Cognitive Trajectories
2026 · Alexandre Tavartkiladze, Russel J. Reiter, et al. · International Journal of Molecular Sciences · 2
PDF
Chronotherapy Enhances Melatonin Secretion and Liver Enzyme Activity, Improving Therapeutic Outcomes in Hodgkins Lymphoma Patients
2024 · A. Tavartkiladze, G. Simonia, et al. · Journal of Cancer Research · 2
PDF
Treatment of refractory recurrent gastrointestinal stromal tumors with adoptive cellular immunotherapy (TILs) and personalized vaccine
2019 · A.A. Tavartkiladze, R. Khutsishvili, et al. · Annals of Oncology · 2
Nocturnal Melatonin Amplitude Collapse Is Associated with Age-Independent Convergence of Microbiome and Glymphatic Biomarkers
2026 · Alexandre Tavartkiladze, Levan Tavartkiladze, et al. · Current Issues in Molecular Biology · 1
Multi-Modal Assessment of LI-RADS 3 and 4 Lesions: Integrating Serum Biomarkers, Liquid Biopsy, and Imaging for Early Hepatocellular Carcinoma Detection and Management
2024 · Alexandre Tavartkiladze · 1
Low Melatonin and Post COVID Syndrome: Unveiling SIBO as a Potential Pre Cancerous Condition in the Post-Pandemic Era
2024 · Maia Maisuradze, Alexandre Tavartkiladze, et al. · Journal of Cancer Research · 1
PDF
The Role of Melatonin and Matrix Metalloproteinases in Breast Cancer Pathogenesis: A Comprehensive Review
2024 · Tavartkiladze A · Advances in Pharmacology & Clinical Trials · 1
Circulating Tumor Cells (CTCs), Melatonin, and uNOS: New Frontiers in Cancer Diagnosis and Treatment
2023 · A. Tavartkiladze, P. Revazishvili, et al. · The Journal of Liquid Biopsy · 1
63P The impact of disruption of melatonin secretion on the structural-functional changes of the microbiome and the role of the melatonin-microbiome axis in the initiation of carcinogenesis
2023 · A.A. Tavartkiladze, T. Potskhoraia, et al. · ESMO Open · 1
PDF
71P Single nucleotide polymorphisms in the folate metabolic pathway genes and global DNA methylation in ovarian cancer
2023 · S. Surmava, E. Kvaratskhelia, et al. · ESMO Open · 1
PDF
Influence of agomelatine and trastuzumab on the HER2/neu(+), MT1 (+) and MT2 (+) chemo and immunoresistant breast cancer cells lines from the previously treated patients by targeted therapy with trastuzumab.
2019 · Alexandre Tavartkiladze, Pati Revazishvili, et al. · Journal of Clinical Oncology · 1
Chronotherapeutic regimen with liposomal cisplatin for systemic treatment of primary liver cancer.
2019 · Levan Tavartkiladze, Alexandre Tavartkiladze, et al. · Journal of Clinical Oncology · 1
Melatonin Inhibits the Metastatic Ability of HER2/neu-negative Breast Cancer Cells by Suppressing Epithelial-to-Mesenchymal Transition (EMT)-Associated Genes with Predictive and Prognostic Relevance
2017 · A. Tavartkiladze, G. Simonia, et al. · Annals of Oncology · 1
Melatonin in the treatment of atherosclerosis
2015 · A. Tavartkiladze, G. Simonia, et al. · Atherosclerosis · 1
Concentration of Blood Serum Melatonin in Patients with Simple and Complex Endometrial Hyperplasia
2014 · Alexandre A. Tavartkiladze, Levan A. Tavartkiladze · Annals of Oncology · 1
Lower 24-hour urinary 6-sulfatoxymelatonin and exploratory bile-acid and microbiome associations in adults with dyslipidemia: a prospectively enrolled cross-sectional study
2026 · Alexandre Tavartkiladze, Levan Tavartkiladze, et al. · Annals of Medicine
PDF
Relative Melatonergic Status and Systemic Inflammatory, Oxidative, and Biological Aging Burden in Adults: An Exploratory Cross-Sectional Biomarker Analysis
2026 · Alexandre Tavartkiladze, Levan Tavartkiladze, et al. · Cancers
AminoTriComplex in Integrative Oncology: Integrated Preclinical Safety and Prospective Clinical Evidence in Metastatic Solid Tumors
2026 · Alexandre Tavartkiladze, Levan Tavartkiladze, et al. · Preprints.org
A Dysbiosis–Urolithin A Depletion–Low 6-Sulfatoxymelatonin Triad as a Composite Biomarker Framework Across Age-Related Vascular and Malignant Disease States
2026 · Alexandre Tavartkiladze, Levan Tavartkiladze, et al. · International Journal of Molecular Sciences
PDF
Subtype-specific melatonin receptor expression on circulating tumor cells and associated inflammatory/metabolic biomarkers in breast cancer: A 3-year cohort analysis (n=171).
2026 · Alexandre Tavartkiladze, Pati Revazishvili, et al. · Journal of Clinical Oncology
Stage-dependent metabolic reprogramming in treatment-naïve lung adenocarcinoma: From oxidative flexibility to glycolytic entrapment.
2026 · Alexandre Tavartkiladze, Pati Revazishvili, et al. · Journal of Clinical Oncology
Works count: 91
Citation count: 513
H-index: 3
I10-index: 1
Year
Topic
Type